Elemental Impurities in Drug Products Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 8, 2018
April 29, 2020
5931c496-e20b-426d-915b-0856db49e99e
Related Documents
Referencing Approved Drug Products in ANDA Submissions Guidance for Industry
Guidance DocumentOctober 27, 2020Center for Drug Evaluation and Research
Bispecific Antibody Development Programs Guidance for Industry
Guidance DocumentMay 24, 2021Center for Drug Evaluation and Research
Labeling for Biosimilar Products Guidance for Industry
Guidance DocumentJuly 18, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox